What We’re Reading: Restoring Eyesight; New Moderna Vaccine Indication Possible; COVID-19 Origin Investigation
Optogenics was used to partially restore a blind man’s eyesight; the FDA could soon approve Moderna’s COVID-19 vaccine for use among adolescents; HHS calls for a new investigation into COVID-19’s origins.
New Gene Therapy Restores Sight in Blind Man
Light-catching proteins were grown in the
Moderna to Ask FDA for Additional COVID-19 Vaccine Approval
Hoping to gain approval for its COVID-19 vaccine among adolescents aged 12 to 17 years, Moderna will submit effectiveness data to the FDA in June, reports
Becerra Stresses Need for New Coronavirus Origins Investigation
Following US intelligence reports that Chinese virology experts were seriously ill before cases of COVID-19 were ever reported in December 2019, HHS Secretary Xavier Becerra is seeking a more transparent phase 2 investigation into the beginnings of the COVID-19 pandemic, according to
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Promising Early Efgartigimod Response Data for Generalized Myasthenia Gravis
September 18th 2025
- Metabolic Issues More Common in Patients With HIV
September 18th 2025
- Barriers to Gender-Affirming Surgery Persist Despite High Satisfaction Rate
September 18th 2025
- Eating Behaviors May Predict GLP-1 Therapy Success in Type 2 Diabetes
September 18th 2025